Ebola: Lessons on Vaccine Development

被引:37
作者
Feldmann, Heinz [1 ,2 ]
Feldmann, Friederike [3 ]
Marzi, Andrea [1 ]
机构
[1] NIAID, Lab Virol, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT 59840 USA
[2] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB 93E 0J9, Canada
[3] NIAID, Rocky Mt Vet Branch, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT 59840 USA
来源
ANNUAL REVIEW OF MICROBIOLOGY, VOL 72 | 2018年 / 72卷
关键词
Ebola virus; animal models; vaccines; clinical trials; challenges; lessons learned; PROTECTS NONHUMAN-PRIMATES; T-CELL RESPONSES; MARBURG VIRUS; DOUBLE-BLIND; HEALTHY-ADULTS; LETHAL EBOLA; DNA VACCINES; GUINEA-PIGS; HEMORRHAGIC-FEVER; VECTORED VACCINE;
D O I
10.1146/annurev-micro-090817-062414
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The West African Ebola virus (EBOV) epidemic has fast-tracked countermeasures for this rare, emerging zoonotic pathogen. Until 2013-2014, most EBOV vaccine candidates were stalled between the preclinical and clinical milestones on the path to licensure, because of funding problems, lack of interest from pharmaceutical companies, and competing priorities in public health. The unprecedented and devastating epidemic propelled vaccine candidates toward clinical trials that were initiated near the end of the active response to the outbreak. Those trials did not have a major impact on the epidemic but provided invaluable data on vaccine safety, immunogenicity, and, to a limited degree, even efficacy in humans. There are plenty of lessons to learn from these trials, some of which are addressed in this review. Better preparation is essential to executing an effective response to EBOV in the future; yet, the first indications of waning interest are already noticeable.
引用
收藏
页码:423 / 446
页数:24
相关论文
共 133 条
[1]   Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe [J].
Agnandji, S. T. ;
Huttner, A. ;
Zinser, M. E. ;
Njuguna, P. ;
Dahlke, C. ;
Fernandes, J. F. ;
Yerly, S. ;
Dayer, J. -A. ;
Kraehling, V. ;
Kasonta, R. ;
Adegnika, A. A. ;
Altfeld, M. ;
Auderset, F. ;
Bache, E. B. ;
Biedenkopf, N. ;
Borregaard, S. ;
Brosnahan, J. S. ;
Burrow, R. ;
Combescure, C. ;
Desmeules, J. ;
Eickmann, M. ;
Fehling, S. K. ;
Finckh, A. ;
Goncalves, A. R. ;
Grobusch, M. P. ;
Hooper, J. ;
Jambrecina, A. ;
Kabwende, A. L. ;
Kaya, G. ;
Kimani, D. ;
Lell, B. ;
Lemaitre, B. ;
Lohse, A. W. ;
Massinga-Loembe, M. ;
Matthey, A. ;
Mordmueller, B. ;
Nolting, A. ;
Ogwang, C. ;
Ramharter, M. ;
Schmidt-Chanasit, J. ;
Schmiedel, S. ;
Silvera, P. ;
Stahl, F. R. ;
Staines, H. M. ;
Strecker, T. ;
Stubbe, H. C. ;
Tsofa, B. ;
Zaki, S. ;
Fast, P. ;
Moorthy, V. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (17) :1647-1660
[2]   Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambarene A, Gabon: A phase I randomised trial [J].
Agnandji, Selidji T. ;
Fernandes, Jose F. ;
Bache, Emmanuel B. ;
Obiang, Regis M. ;
Brosnahan, Jessica S. ;
Kabwende, Lumeka ;
Pitzinger, Paul ;
Staarink, Pieter ;
Massinga-Loembe, Marguerite ;
Kraehling, Verena ;
Biedenkopf, Nadine ;
Fehling, Sarah Katharina ;
Strecker, Thomas ;
Clark, David J. ;
Staines, Henry M. ;
Hooper, Jay W. ;
Silvera, Peter ;
Moorthy, Vasee ;
Kieny, Marie-Paule ;
Adegnika, Akim A. ;
Grobusch, Martin P. ;
Becker, Stephan ;
Ramharter, Michael ;
Mordmueller, Benjamin ;
Lell, Bertrand ;
Krishna, Sanjeev ;
Kremsner, Peter G. .
PLOS MEDICINE, 2017, 14 (10)
[3]  
[Anonymous], 2016, Ebola Situation Report
[4]  
[Anonymous], 2014, REALSTAR EBOLAVIRUS
[5]   Rapid outbreak sequencing of Ebola virus in Sierra Leone identifies transmission chains linked to sporadic cases [J].
Arias, Armando ;
Watson, Simon J. ;
Asogun, Danny ;
Tobin, Ekaete Alice ;
Lu, Jia ;
Phan, My V. T. ;
Jah, Umaru ;
Wadoum, Raoul Emeric Guetiya ;
Meredith, Luke ;
Thorne, Lucy ;
Caddy, Sarah ;
Tarawalie, Alimamy ;
Langat, Pinky ;
Dudas, Gytis ;
Faria, Nuno R. ;
Dellicour, Simon ;
Kamara, Abdul ;
Kargbo, Brima ;
Kamara, Brima Osaio ;
Gevao, Sahr ;
Cooper, Daniel ;
Newport, Matthew ;
Horby, Peter ;
Dunning, Jake ;
Sahr, Foday ;
Brooks, Tim ;
Simpson, Andrew J. H. ;
Groppelli, Elisabetta ;
Liu, Guoying ;
Mulakken, Nisha ;
Rhodes, Kate ;
Akpablie, James ;
Yoti, Zabulon ;
Lamunu, Margaret ;
Vitto, Esther ;
Otim, Patrick ;
Owilli, Collins ;
Boateng, Isaac ;
Okoror, Lawrence ;
Omomoh, Emmanuel ;
Oyakhilome, Jennifer ;
Omiunu, Racheal ;
Yemisis, Ighodalo ;
Adomeh, Donatus ;
Ehikhiametalor, Solomon ;
Akhilomen, Patience ;
Aire, Chris ;
Kurth, Andreas ;
Cook, Nicola ;
Baumann, Jan .
VIRUS EVOLUTION, 2016, 2 (01)
[6]   Discovery of Swine as a Host for the Reston ebolavirus [J].
Barrette, Roger W. ;
Metwally, Samia A. ;
Rowland, Jessica M. ;
Xu, Lizhe ;
Zaki, Sherif R. ;
Nichol, Stuart T. ;
Rollin, Pierre E. ;
Towner, Jonathan S. ;
Shieh, Wun-Ju ;
Batten, Brigid ;
Sealy, Tara K. ;
Carrillo, Consuelo ;
Moran, Karen E. ;
Bracht, Alexa J. ;
Mayr, Gregory A. ;
Sirios-Cruz, Magdalena ;
Catbagan, Davinio P. ;
Lautner, Elizabeth A. ;
Ksiazek, Thomas G. ;
White, William R. ;
McIntosh, Michael T. .
SCIENCE, 2009, 325 (5937) :204-206
[7]   The Pathogenesis of Ebola Virus Disease [J].
Baseler, Laura ;
Chertow, Daniel S. ;
Johnson, Karl M. ;
Feldmann, Heinz ;
Morens, David M. .
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 12, 2017, 12 :387-418
[8]   Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine [J].
Blaney, Joseph E. ;
Marzi, Andrea ;
Willet, Mallory ;
Papaneri, Amy B. ;
Wirblich, Christoph ;
Feldmann, Friederike ;
Holbrook, Michael ;
Jahrling, Peter ;
Feldmann, Heinz ;
Schnell, Matthias J. .
PLOS PATHOGENS, 2013, 9 (05)
[9]   Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses [J].
Blaney, Joseph E. ;
Wirblich, Christoph ;
Papaneri, Amy B. ;
Johnson, Reed F. ;
Myers, Carey J. ;
Juelich, Terry L. ;
Holbrook, Michael R. ;
Freiberg, Alexander N. ;
Bernbaum, John G. ;
Jahrling, Peter B. ;
Paragas, Jason ;
Schnell, Matthias J. .
JOURNAL OF VIROLOGY, 2011, 85 (20) :10605-10616
[10]  
Branswell H., 2017, STAT 1208